Perceived barriers to timely treatment initiation and social support status among women with breast cancer in Ethiopia.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 17 05 2021
accepted: 24 08 2021
entrez: 13 9 2021
pubmed: 14 9 2021
medline: 18 11 2021
Statut: epublish

Résumé

Timely care is essential to increase breast cancer survival. However, patients in Ethiopia still face multilevel barriers on their pathway to timely treatment initiation. This cross-sectional study at Tikur Anbessa Specialized Hospital Oncology Unit in Addis Ababa assessed systemic treatment initiation intervals of breast cancer patients and quantified the impact of socio-demographic and clinical factors, perceived barriers, and the patients´ perceived social support status on timely systemic treatment initiation (chemotherapy or hormonal therapy). A structured questionnaire was designed based on Pechansky´s "Concept of Access". Applying simple and multivariate logistic regression we analysed the influence of patients´ characteristics as well as their perceived barriers on timely treatment initiation. We measured social support with the Multidimensional Score of Perceived Social Support (MSPSS) and used the Wilcoxon Rank-Sum Test to assess its relationship with timely treatment initiation. Of 196 patients included into the study, 53% received systemic treatment within 90 days of their pathological diagnosis-the median treatment initiation interval was 85 days (IQR 123.5). Older women and patients diagnosed at late stages had higher odds of timely treatment initiation. Not being able to pay for services and lack of transport were most often perceived as barriers towards timely care. However, none of the perceived barriers showed a substantial influence on timely treatment initiation in the multivariate regression model. The patients´ perceived social support was found to be high, with an average MSPSS score of 73 out of 84 (SD 13,63). No impact of the perceived social support status on timely treatment initiation was found. The percentage of breast cancer patients waiting longer than 90 days from pathological diagnosis to systemic treatment initiation in Ethiopia remains unacceptably high. While women generally feel well supported by their social environment, costs and accessibility of treatment are perceived to be major barriers towards timely treatment initiation.

Identifiants

pubmed: 34516552
doi: 10.1371/journal.pone.0257163
pii: PONE-D-21-16175
pmc: PMC8437283
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0257163

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

BMC Cancer. 2018 Mar 21;18(1):312
pubmed: 29562894
BMC Cancer. 2019 Aug 27;19(1):836
pubmed: 31455282
J Clin Oncol. 2006 Mar 1;24(7):1105-11
pubmed: 16505430
Breast Care (Basel). 2018 Mar;13(1):39-43
pubmed: 29950966
BMC Womens Health. 2020 Mar 11;20(1):50
pubmed: 32160874
Oncologist. 2019 Dec;24(12):e1371-e1380
pubmed: 31387949
J Health Serv Res Policy. 2012 Apr;17(2):110-8
pubmed: 22008712
Oncologist. 2018 Dec;23(12):1453-1460
pubmed: 30082488
PLoS One. 2019 Sep 19;14(9):e0219519
pubmed: 31536505
Cancer Epidemiol Biomarkers Prev. 1994 Apr-May;3(3):253-9
pubmed: 8019376
Breast Cancer Res. 2019 Aug 13;21(1):93
pubmed: 31409419
Int J Cancer. 2020 Mar 1;146(5):1208-1218
pubmed: 31087650
Med Care. 1981 Feb;19(2):127-40
pubmed: 7206846
Ann Surg Oncol. 2018 Oct;25(10):2829-2838
pubmed: 29968031
J Glob Oncol. 2018 Aug;4:1-13
pubmed: 30199305
Int J Cancer. 2014 Aug 1;135(3):702-9
pubmed: 24375396
PLoS One. 2018 Nov 29;13(11):e0207928
pubmed: 30496219
Breast Cancer Res Treat. 2021 Jun;187(3):877-882
pubmed: 33599864
Lancet Glob Health. 2019 Oct;7(10):e1375-e1387
pubmed: 31537368
Ann Epidemiol. 2017 Oct;27(10):659-671.e7
pubmed: 29128086

Auteurs

Bethel Teshome (B)

Department of Preventive Medicine, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.

Josephin Trabitzsch (J)

Institute for Medical Epidemiology, Biometrics and Informatics, Martin-Luther-University Halle-Wittenberg, Halle Saale, Germany.

Tsion Afework (T)

Department of Preventive Medicine, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.

Adamu Addissie (A)

Department of Preventive Medicine, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.
Institute for Medical Epidemiology, Biometrics and Informatics, Martin-Luther-University Halle-Wittenberg, Halle Saale, Germany.

Mirgissa Kaba (M)

Department of Preventive Medicine, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.

Eva Johanna Kantelhardt (EJ)

Institute for Medical Epidemiology, Biometrics and Informatics, Martin-Luther-University Halle-Wittenberg, Halle Saale, Germany.
Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle Saale, Germany.

Sefonias Getachew (S)

Department of Preventive Medicine, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.
Institute for Medical Epidemiology, Biometrics and Informatics, Martin-Luther-University Halle-Wittenberg, Halle Saale, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH